Receptor-specific induction of NF-κB components in primary B cells

International Immunology

Volumn 10, Issue 3, 1998, Pages 285-293

  Francis, Delicia A ^a   Sen, Ranjan ^b   Rice, Nancy ^c   Rothstein, Thomas L ^a,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRANDEIS UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

B cell antigen receptor; B lymphocytes; CD40 receptor; DNA binding proteins; I B proteins; RelB protein; Transcription factors

Indexed keywords

CD40 ANTIGEN; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, B-CELL; TIME FACTORS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0031914040     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.3.285     Document Type: Article

References (52)

1. Gold, M. R. and De Franco, A. L. 1994. Biochemistry of B lymphocyte activation. Adv. Immunol. 55:221.
2. Siebenlist, U., Franzoso, G. and Brown, K. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
3. Bauerle, P. and Henkel, T. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141.
4. Thanos, D. and Maniatis, T. 1995. NF-κB: a lesson in family values. Cell 80:529.
5. Palombella, V. J., Rando, O. J., Goldberg, A. L. and Maniatis, T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773.
6. Naumann, M., Nieters, A., Hatada, E. N. and Scheidereit, C. 1993. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/Rel factors. Oncogene 8:2275.
7. Scheinman, R. I., Beg, A. A. and Baldwin, A. S. 1993. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B like molecule. Mol. Cell. Biol. 13:6089.
8. Mercurio, F., DiDonato, J. A., Rosette, C. and Karin, M. 1993. p105 and p98 precursor proteins play an active role in NF-κB mediated signal transduction. Genes Dev 7:705.
9. Rice, N. R., MacKichan, M. L. and Israel, A. 1992. The precursor of NF-κB p50 has IκB like functions. Cell 71:243.
10. Kamens, J. Richardson, P., Mosialos, G., Brent, R. and Gilmore, T. 1990. Oncogenic transformation by v-rel requires an aminoterminal activation domain. Mol. Cell. Biol 10:2840
11. Sun, S. C., Ganchi, P. A., Beraud, C., Ballard, D. W. and Greene, W. C. 1994. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl Acad. Sci. USA 91:1346.
12. Dobrzanski, P., Ryseck, R.-T. and Bravo, R. 1993. Both N- and C-terminal domains of ReIB are required for full transactivation: Role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13:1572.
13. Lernbecher, T., Muller, U. and Wirth, T. 1993. Distinct NF-κB/ Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767.
14. Perkins, N. D., Schmid, R. M., Duckett, C. S., Leung, K. and Rice, N. R. and Nabel, G. J. 1992. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl Acad. Sci. USA 89:1529.
15. Ryseck, R.-P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P. and Bravo, R. 1992. ReIB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674.
16. Zabel, U. and Baeurle, P. A. 1990. Purified human IkB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61:255.
17. Kerr, L. D., Inoue, J., Davis, N., Link, E., Baeurle, P. A., Bose, H. R., Jr and Verma, I. M. 1991. The rei-associated pp40 protein prevents DNA binding of Rei and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev. 5:1464.
18. Inoue, J., Kerr, L. D., Kakizuka, A. and Verma, I. M. 1992. IκBγ, a 70kD protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell 68:1109.
19. Wulczyn, F. G., Nauman, M. and Scheidereit, C. 1992. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature 358:597.
20. Hatada, E. N., Nieters A., Wulczyn, F. G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T. W. and Scheidereit, C. 1992. The ankyrin repeat domains of the NF-kappa B precursor p105 and the proto-oncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc. Natl Acad. Sci. USA 89:2489.
21. Dobrzanski, P., Ryseck, R. and Bravo, R. 1994. Differential interactions of Rel/NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J. 13:460823.
22. Naumann, M., Wulczyn, F. G. and Scheidereit, C. 1993. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kaopa B molecules and control nuclear translocation of NF-κB. EMBO J. 12:213.
23. Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A. and Baldwin, A. S. Jr. 1992. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 6:1899.
24. Baeurle, P. A. and Baltimore, D. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242:540.
25. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A. and Ben-Neriah, Y. 1995. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 92:10599.
26. Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T. and Ballard, D. W. 1995. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl Acad. Sci. USA 92:11259.
27. Sen, R. and Baltimore, D. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
28. Francis, D. A., Karras, J. G., Ke, X., Sen, R. and Rothstein, T. L. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151.
29. Liu, J., Chiles, T. C., Sen, R. and Rothstein, T. L. 1991. Inducible nuclear expression of NF-κB in primary B cells stimulated through the surface Ig receptor. J. Immunol. 146:1685.
30. Banchereau, J., Bazan, F., Blanchard, D., Briere, F. Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F. and Saeland, S. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
31. Smith, C. A., Farrah, T. and Goodwin, R. G. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959.
32. Fuleihan, R., Ramesh, N. and Geha, R. S. 1993. Role of CD40-CD40-ligand interaction in Ig-isotype switching. Curr. Opin. Immunol. 5:963.
33. Lawrence, R., Chang, L. J., Siebenlist, U., Bressler, P. and Sonenshein, G. E. 1994. Vascular smooth muscle cells express a constitutive NF-kappa B-like activity. J. Biol. Chem. 269:28913.
34. Lin, R., Gewert, D. and Hiscott, J. 1995. Differential transcriptional actiation in vitro by NF-κB/Rel Proteins. J. Biol. Chem. 270:3123.
35. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
36. Demczuk, S., Harbers, M. and Vennstrom, B. 1993. Identification and analysis of all components of a gel retardation assay by combination with immunoblotting. Proc. Natl Acad. Sci. USA 90:2574.
37. Berberich, I. Shu, G. L. and Clark, E. A. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:4357.
38. Liou, H., Sha, W. C., Scott, M. L. and Baltimore, D. 1994. Sequential induction of NF-κB/Rel family proteins during B cell terminal differentiation. Mol. Cell. Biol. 14:5349.
39. Miyamoto, S., Schmitt, M. J. and Verma, I. M. 1994. Qualitative changes in the subunit composition of κB binding complexes during murine B cell differentiation. Proc. Natl Acad. Sci. USA 91:5056.
40. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A. and Bravo, R. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of ReIB, a member of the NF-κB/Rel family. Cell 80:331.
41. Weih, F., Lira, S. A. and Bravo, R. 1996. Overexpression of ReIB in transgenic mice does not affect IκBα levels: differential regulation of ReIA and ReIB by the inhibitor protein. Oncogene 12:445.
42. Weih, F., Carrasco, D. and Bravo, R. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene 9:3289.
43. Lalmanach-Girard, A.-C., Chiles, T. C., Parker, D. C. and Rothstein, T. L. 1993. T cell-dependent induction of NF-κB in B cells. J. Exp. Med. 177:1215.
44. Neumann, M., Wohlleben, G., Chuvpilo, S., Kistler, B., Wirth, T., Serfling, E. and Schimpl, A. 1996. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of ReIB. J. Immunol. 157:4862.
45. Gerondakis, S., Gaff, C., Goodman, D. J. and Grumont, R. J. 1991. Structure and expression of mouse germline immunoglobulin γ3 heavy chain transcripts induced by the mitogen lipopolysaccharide. Immunogenetics 34:392.
46. Delphin, S, and Stavnezer, J. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline ε promoter: regulation by NF-IL-4, a C/EBP family member and NF-κB/p50. J. Exp. Med. 181:181.
47. Snapper, C. M., Rosas, F. R., Zelazowski, P., Moorman, M. A., Kehry, M. R., Bravo, R. and Weih, F. 1996. B cells lacking ReIB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184:1537.
48. Tanguay, D. A., Dickinson, J. A., McManus, B. J., Huo, L., Rothstein, T. L. and Chiles, T. C. 1994. Activation of AP-1 in primary B lymphocytes by surface immunoglobulin requires de novo Jun-B synthesis. Cell. Immunol. 158:281.
49. Huo, L. and Rothstein, T. L. 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154:3300.
50. Karras, J. G., Wang, Z., Coniglio, S. J., Frank, D. A. and Rothstein, T. L. 1996. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site. J. Immunol. 157:39.
51. Karras, J. G., Wang, Z., Frank, D. A., Zimmet, J. M. and Rothstein, T. L. 1996. Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes. J. Immunol. 157:2299.
52. Karras, J. G., Wang, Z., Huo, L., Howard, R. G., Frank, D. A. and Rothstein, T. L. 1996. Signal Transducer and Activator of Transcription-3 (STAT3) is constitutively activated in normal, self-renewing B 1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185:1035.